Search results

Order by most recent / most popular / relevance

Results: 1-10 of 55

Myanmar signs the New York Convention: additional investment protection

Herbert Smith Freehills LLP
-
Myanmar
-
May 13 2013

Since the change of regime in March 2011, the government of Myanmar has sought to promote foreign investment, leading to wide-ranging changes to the

Arbitration in South Korea: a new phase begins

Herbert Smith Freehills LLP
-
South Korea
-
April 8 2013

Whilst the Korean Commercial Arbitration Board ("KCAB") has reported growth in the number of international arbitrations, South Korea is seldom

IP-rich Japanese companies may face new competition issues in Europe: CJEU's decision in AstraZeneca

Herbert Smith Freehills LLP
-
European Union, Japan
-
March 25 2013

Japanese companies that enjoy a dominant position in a particular market in Europe are likely to be aware that they are subject to high standards of

Singapore High Court decisions show active support for arbitration

Herbert Smith Freehills LLP
-
Singapore
-
March 11 2013

Singapore has long been favoured as a seat for international arbitration by Japanese and multinational companies alike. With many Japanese companies

Unilateral jurisdiction clauses may not always be effective

Herbert Smith Freehills LLP
-
United Kingdom
-
February 12 2013

Dispute resolution clauses that give one party the right to choose where disputes will be resolved are not uncommon, particularly in finance

EU patent package agreed and approved

Herbert Smith Freehills LLP
-
European Union
-
January 28 2013

The EU unitary patent ("UP") system is marching closer to reality following a recent flurry of activity. On 11 December 2012, the European Parliament

Terminating distribution agreements know where you stand

Herbert Smith Freehills LLP
-
Japan
-
January 11 2013

A distribution agreement is a contract under which a seller (the "distributor") markets and distributes products which it has purchased from a

The UK government proposes better protection for pharmaceutical companies conducting clinical trials

Herbert Smith Freehills LLP
-
European Union, United Kingdom
-
November 27 2012

As many Japanese companies in the healthcare and veterinary fields may have experienced or be aware, obtaining regulatory approval to market a drug in Europe can be time-consuming and often challenging

Arbitration in England: major court decisions of 20112012

Herbert Smith Freehills LLP
-
United Kingdom
-
November 5 2012

This newsletter provides a snapshot of some of the key English judgments of 2011 and 2012 of interest to those involved, or potentially involved, in international arbitrations seated in London and therefore procedurally governed by English law

Further update on the EU patent package

Herbert Smith Freehills LLP
-
European Union
-
September 24 2012

For many decades, the patent system in Europe has been under review

next >

Search results

Myanmar signs the New York Convention: additional investment protection

Arbitration in South Korea: a new phase begins

IP-rich Japanese companies may face new competition issues in Europe: CJEU's decision in AstraZeneca

Singapore High Court decisions show active support for arbitration

Unilateral jurisdiction clauses may not always be effective

EU patent package agreed and approved

Terminating distribution agreements know where you stand

The UK government proposes better protection for pharmaceutical companies conducting clinical trials

Arbitration in England: major court decisions of 20112012

Further update on the EU patent package

Current Search

Suggested Facets

Author

Jurisdiction

Workarea